- An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
-
Lee SW, Kim YM, Kim YT, Kang SB
- KMID: 2413442
- J Gynecol Oncol.
- 2017 May;28(3):e26.
- doi: 10.3802/jgo.2017.28.e26
OBJECTIVE: This phase I study aimed to determine the maximum tolerated dose (MTD) of Genexol-PM, when combined with carboplatin, as a first-line treatment in patients with advanced ovarian cancer. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
